UPSA

UPSA, a distinguished French pharmaceutical company, has been a cornerstone of healthcare since its founding in 1935. Specializing in the development and manufacturing of over-the-counter (OTC) medications, UPSA focuses on improving everyday well-being through its extensive range of treatments. The company's core therapeutic areas include effective pain relief, comprehensive ear and throat health solutions, digestive support, and aids for sleep quality. With decades of dedicated experience, UPSA has cultivated a reputation for producing trusted, accessible medicines that empower individuals to manage common health concerns and enhance their comfort.

Operating with a significant workforce of 1,000-5,000 employees, UPSA generates substantial revenue, reported at $814.8M. This scale of operation supports its mission to deliver reliable pharmaceutical products. The company's commitment to quality and efficacy is evident in its long-standing presence in the market. Meet UPSA's team to understand the expertise driving its product development and market strategy. UPSA's product portfolio, including its SAS offerings, is designed to meet the daily health needs of consumers across various regions, leveraging its deep historical knowledge and modern pharmaceutical capabilities.

As a key player in the European pharmaceutical landscape, particularly within France and Belgium, UPSA leverages its extensive history to build consumer trust. Its B2B and B2C approaches ensure broad market penetration for its essential medications. The company's strategic focus on accessible, non-prescription treatments positions it as a vital resource for public health, addressing prevalent issues like pain, sleep disturbances, and digestive discomfort. UPSA's enduring legacy is built on consistent delivery of health solutions.